New asthma injection shows promise in phase 2 trial
Disease control
Not yet recruiting
This study tests an experimental drug called RC1416 in adults with moderate to severe asthma that is not well controlled. The goal is to see if it can improve lung function and reduce asthma attacks. About 195 participants will receive either the drug or a placebo, and researcher…
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC